Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Guay

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|June 3, 1994
Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged plateletsD Riendeau, J Guay, P K Weech, et al.
Journal of Lipid Mediators|March 1, 1993
A new class of leukotriene biosynthesis inhibitor: the development of MK-0591P Prasit, M Belley, M Blouin, et al.
Canadian Journal of Physiology and Pharmacology|June 1, 1992
Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitorC Brideau, C Chan, S Charleson, et al.
Journal of Medicinal Chemistry|April 15, 1994
Thiopyrano[2,3,4-cd]indoles as 5-lipoxygenase inhibitors: synthesis, biological profile, and resolution of 2-[2-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5 -dihydro-1H-thiopyrano[2,3,4-cd]indol-2-yl]ethoxy]butanoic acidJ H Hutchinson, D Riendeau, C Brideau, et al.
Journal of Medicinal Chemistry|February 18, 1994
Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybridsY Ducharme, C Brideau, D Dubé, et al.
Molecular Pharmacology|May 1, 1992
Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibitionS Charleson, P Prasit, S Léger, et al.
Journal of Pediatric Surgery|August 1, 1991
Infectious complications of pediatric liver transplantationD Saint-Vil, F I Luks, P Lebel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 25, 2011
Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthmaG N Kaufman, A H Massoud, S Audusseau, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530D Dubé, M Blouin, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitorsR Frenette, J H Hutchinson, S Léger, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|June 3, 1994
Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged plateletsD Riendeau, J Guay, P K Weech, et al.
Journal of Lipid Mediators|March 1, 1993
A new class of leukotriene biosynthesis inhibitor: the development of MK-0591P Prasit, M Belley, M Blouin, et al.
Canadian Journal of Physiology and Pharmacology|June 1, 1992
Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitorC Brideau, C Chan, S Charleson, et al.
Journal of Medicinal Chemistry|April 15, 1994
Thiopyrano[2,3,4-cd]indoles as 5-lipoxygenase inhibitors: synthesis, biological profile, and resolution of 2-[2-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5 -dihydro-1H-thiopyrano[2,3,4-cd]indol-2-yl]ethoxy]butanoic acidJ H Hutchinson, D Riendeau, C Brideau, et al.
Journal of Medicinal Chemistry|February 18, 1994
Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybridsY Ducharme, C Brideau, D Dubé, et al.
Molecular Pharmacology|May 1, 1992
Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibitionS Charleson, P Prasit, S Léger, et al.
Journal of Pediatric Surgery|August 1, 1991
Infectious complications of pediatric liver transplantationD Saint-Vil, F I Luks, P Lebel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 25, 2011
Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthmaG N Kaufman, A H Massoud, S Audusseau, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530D Dubé, M Blouin, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitorsR Frenette, J H Hutchinson, S Léger, et al.
Pageof 7